SARS-CoV-2 Variants: Clinical, Vaccine, and Public Health Implications​

  • Published: November 29, 2021

We hope you enjoy this next instalment in our event summaries that we are preparing on a selection of our previous Speaker Series events. Each summary provides the reader with the presentation’s objective, what we heard as the key messages, next steps, and a link to the event’s recording. While this event series is conducted in English, these summaries have been translated into French.


C Kaushic


To summarize the Speaker Series presentation led by Dr. Kaushic on ‘SARS-CoV-2 Variants: Clinical, Vaccine, and Public Health Implications.’ This presentation was held on February 9, 2021. The aim of her talk was to provide attendees with an overview of the information regarding the SARS-CoV-2 variants and emerging evidence on the effect of variants on public health, clinical outcomes, and vaccines efficacy.

With funding from the Government of Canada

Please complete this short survey to help us understand our impact. Thank you!

Give Feedback